Lifetime comorbid substance misuse in patients newly diagnosed with bipolar disorder
Journal of Affective Disorders · 2026-11 · 412 · 122142
DOI: 10.1016/j.jad.2026.122142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-11. Verfasst von S Stanislaus und 9 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Centre of Copenhagen, Denmark. Electronic address: Sharleny.stanislaus.01@regionh…. Hauptthemen laut MEDLINE: Bipolar Disorder, Substance-Related Disorders. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Beckett-Fonden, Fonden til Lægevidenskabens Fremme, Lundbeck Foundation.
Abstract (Originalsprache)
BACKGROUND Comorbid substance use is common in patients with bipolar disorder (BD) and associated with a more severe illness course and higher mortality rates. We aimed to investigate 1) the prevalence of lifetime comorbid substance misuse in patients with newly diagnosed BD compared with healthy controls (HC), and 2) differences in illness characteristics between patients with and without comorbid substance misuse. METHODS We included 376 patients with newly diagnosed BD and 200 HC. Lifetime substance misuse (including alcohol and drug use) was identified through baseline interview and through systematic review of electronic health records. RESULTS The prevalence of lifetime substance misuse was higher for patients with newly diagnosed BD (43%). Patients with BD had a high prevalence of lifetime comorbid drug misuse (38%) than alcohol misuse (19%). Among patients, lifetime substance misuse was associated with male sex (OR = 2.86 [1.82; 4.55] p < 0.001), childhood trauma (β = 5.33 [2.68; 7.99], p = 0.003), BD type I (OR = 1.71 [1.09; 2.68], p = 0.042), presence of suicide attempts (OR = 2.26 [1.36; 3.75], p = 0.005) and more sick days the preceding year (β = 41.43 [16.90; 65.96], p = 0.012). LIMITATIONS Information regarding substance use was partly gathered retrospectively using electronic health records. HC were recruited among blood donors and may not be representative of the general population. CONCLUSION We found a high prevalence of lifetime comorbid substance misuse, particularly drug misuse in patients with newly diagnosed BD. Lower clinical focus on drug use than alcohol may have contributed to higher observed prevalence of drug use. This highlights the need for early clinical assessment and integrated treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Centre of Copenhagen, Denmark. Electronic address: Sharleny.stanislaus.01@regionh.dk.
- Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Centre of Copenhagen, Denmark.
- Neurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Frederiksberg Hospital, Mental Health Services, Capital Region of Denmark, Denmark.
- Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Centre of Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
- Neurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Frederiksberg Hospital, Mental Health Services, Capital Region of Denmark, Denmark; Department of Clinical Medicine, Faculty of Health and Medical…
- Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Centre of Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; The Early Mu…
Förderung
- Beckett-Fonden
- Fonden til Lægevidenskabens Fremme
- Lundbeck Foundation
- Region Hovedstadens Psykiatri
- Sundhed og Sygdom, Det Frie Forskningsråd
- Region Hovedstaden
Zitieren
APA
Stanislaus, S., Thirstrup, C. F., Kjærstad, H. L., Sletved, K. S. O., Faurholt-Jepsen, M., Munkholm, K., Miskowiak, K. W., Vinberg, M., Coello, K., & Kessing, L. V. (2026). Lifetime comorbid substance misuse in patients newly diagnosed with bipolar disorder. Journal of Affective Disorders, 412, 122142. https://doi.org/10.1016/j.jad.2026.122142
Vancouver
Stanislaus S, Thirstrup CF, Kjærstad HL, Sletved KSO, Faurholt-Jepsen M, Munkholm K, et al. Lifetime comorbid substance misuse in patients newly diagnosed with bipolar disorder. Journal of Affective Disorders. 2026;412:122142. doi:10.1016/j.jad.2026.122142
BibTeX
@article{Stanislaus2026,
author = {Stanislaus, S and Thirstrup, C F and Kjærstad, H L and Sletved, K S O and Faurholt-Jepsen, M and Munkholm, K and Miskowiak, K W and Vinberg, M and Coello, K and Kessing, L V},
title = {Lifetime comorbid substance misuse in patients newly diagnosed with bipolar disorder},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {412},
pages = {122142},
doi = {10.1016/j.jad.2026.122142}
}
EUVIMED